Hope for chronically suicidal patient: evaluating the clinical and health services impact of dialectical behaviour therapy (DBT) in individuals with borderline personality disorder

ISRCTN ISRCTN02634417
DOI https://doi.org/10.1186/ISRCTN02634417
Secondary identifying numbers MCT-58343
Submission date
16/11/2005
Registration date
16/11/2005
Last edited
21/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Dr Shelley Frances McMain
Scientific

Centre for Addiction and Mental Health
33 Russell St.
Toronto
M5S 2S1
Canada

Phone +1 416 535 8501 ext. 6852
Email shelley_McMain@camh.net

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleEvaluating the clinical and health services impact of dialectical behaviour therapy (DBT) in individuals with borderline personality disorder: a randomised controlled trial
Study hypothesisTo evaluate the clinical and cost effectiveness of dialectical behaviour therapy (DBT) for chronically suicidal patients with borderline personality disorder (BPD).
Ethics approval(s)Research Ethics Board of Centre for Addiction and Mental Health, University of Toronto approved on 28th October 2002
ConditionBorderline personality disorder (BPD)
Intervention1. Dialectical behaviour therapy (Linehan, 1993)
2. General Psychiatric Management based on the American Psychiatric Association (APA) practice guidelines

Trial details received: 12 Sept 2005
Intervention typeOther
Primary outcome measureParasuicidal behaviour
Secondary outcome measures1. Psychiatric hospitalisation
2. Psychiatric symptoms
3. Anger
4. Treatment retention
5. Social functioning
Overall study start date01/10/2002
Overall study end date30/09/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants180
Participant inclusion criteria1. Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) criteria for BPD
2. Be between 18 - 60 years of age, either sex
3. Have had two Para-suicide episodes in the past 5 years with one occurring in the past 3 months
4. Have had OHIP insurance coverage for 1 year or more
5. Be literate in English
6. Provide informed consent to participate in study
7. Agree to be compliant with prescribed psychotropic medication(s)
Participant exclusion criteria1. Current active substance dependence disorder
2. Psychotic disorder, bipolar or dementia
3. Evidence of an organic brain syndrome or mental retardation
4. Chronic or serious physical health problem that may require hospitalisation with the next year
5. Medical condition that would preclude the psychiatric medication regimen
6. Currently engaged in DBT or in GPM at St Michael's Hospital
Recruitment start date01/10/2002
Recruitment end date30/09/2007

Locations

Countries of recruitment

  • Canada

Study participating centre

Centre for Addiction and Mental Health
Toronto
M5S 2S1
Canada

Sponsor information

The Centre for Addiction and Mental Health (Toronto) (Canada)
Hospital/treatment centre

33 Russell Street
Toronto
M5S 2S1
Canada

Website http://www.camh.net/
ROR logo "ROR" https://ror.org/03e71c577

Funders

Funder type

Research organisation

Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-58343)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2009 Yes No